Aion Therapeutic Inc.
ANTCF
OTC PK
10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 700.00 | 300.00 | 200.00 | -- | 9.90K |
Total Receivables | 212.90K | -- | 145.50K | 133.60K | 125.80K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 1.30K | -- | -- | -- | 21.20K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 13.30K | -- | -- | -- | -- |
Total Current Assets | 228.20K | -- | 145.80K | 133.60K | 156.90K |
|
|||||
Total Current Assets | 228.20K | -- | 145.80K | 133.60K | 156.90K |
Net Property, Plant & Equipment | -- | -- | -- | -- | 26.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 237.50K | -- | 155.40K | 470.60K | 512.40K |
|
|||||
Total Accounts Payable | 1.27M | -- | 1.24M | 1.00M | 891.70K |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | 748.20K | -- | 715.50K | 703.50K | 743.50K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | 14.30K |
Total Finance Division Other Current Liabilities | 154.60K | -- | 209.10K | 163.20K | 127.00K |
Total Other Current Liabilities | 154.60K | -- | 209.10K | 163.20K | 127.00K |
Total Current Liabilities | 2.17M | -- | 2.17M | 1.87M | 1.78M |
|
|||||
Total Current Liabilities | 2.17M | -- | 2.17M | 1.87M | 1.78M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 748.20K | -- | 715.50K | 703.50K | 743.50K |
Capital Leases | -- | -- | -- | -- | 12.30K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 2.17M | -- | 2.17M | 1.87M | 1.79M |
|
|||||
Common Stock & APIC | 11.39M | -- | 11.19M | 11.38M | 11.13M |
Retained Earnings | -14.82M | -- | -14.81M | -14.51M | -14.03M |
Treasury Stock & Other | 1.49M | -- | 1.60M | 1.73M | 1.63M |
Total Common Equity | -1.94M | -2.07M | -2.01M | -1.40M | -1.28M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -1.94M | -2.07M | -2.01M | -1.40M | -1.28M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -1.94M | -2.07M | -2.01M | -1.40M | -1.28M |
|